Bridgecreek Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bridgecreek Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,700	Closed	-$253K	–	104
2016 Q3	$253K	Hold	4,700	–	–	0.08%	90
2016 Q2	$346K	Hold	4,700	–	–	0.11%	78
2016 Q1	$300K	Hold	4,700	–	–	0.1%	77
2015 Q4	$323K	Hold	4,700	–	–	0.1%	76
2015 Q3	$278K	Hold	4,700	–	–	0.08%	81
2015 Q2	$313K	Hold	4,700	–	–	0.08%	91
2015 Q1	$303K	Sell	4,700 -300	-6%	-$18.8K	0.07%	96
2014 Q4	$295K	Buy	5,000 +91	+2%	+$5.13K	0.08%	91
2014 Q3	$251K	Hold	4,909	–	–	0.07%	94
2014 Q2	$238K	Hold	4,909	–	–	0.06%	97
2014 Q1	$255K	Hold	4,909	–	–	0.07%	96
2013 Q4	$261K	Buy	4,909 +209	+4%	+$10.6K	0.08%	96
2013 Q3	$218K	Hold	4,700	–	–	0.06%	105
2013 Q2	$210K	Buy	+4,700	New	+$204K	0.07%	95

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bridgecreek Investment Management's BMY Position: Q4 2016 in Review

Bridgecreek Investment Management sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 4,700 shares — an estimated $253K sold.

Bridgecreek Investment Management first reported a position in BMY in Q2 2013 and held it in 14 quarters. The position peaked at $346K in Q2 2016. 1,602 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

Bridgecreek Investment Management reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
Bridgecreek Investment Management sold 4,700 Bristol-Myers Squibb shares in Q4 2016, an estimated $253K.
Bridgecreek Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 14 quarters.
Bridgecreek Investment Management's Bristol-Myers Squibb position peaked at $346K in Q2 2016.
1,602 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Bridgecreek Investment Management's 13F filing for Q4 2016, filed 25 Jan 2017.